BNTX stock slips after cancer vaccine trial halt, BMO calls it clear setback
BNTX is on track for its worst day since March following a cancer vaccine trial halt, per TradingView News citing BMO Capital.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.